Skip to content
Screener

PROCEPT BioRobotics Corporation PRCT Operating Income

Operating Income at other companies

TFX
TeleflexTFX
$72.82M-20.1%
Boston Scientific logo
Boston ScientificBSX
$1.18B+43.8%
Intuitive Surgical logo
Intuitive SurgicalISRG
$971.9M+30.7%
PDE
Pro-Dex, Inc.PDEX
$3.09M-15.0%
Microbot Medical logo
Microbot MedicalMBOT
-$4.32M-43.0%
iRadimed logo
iRadimedIRMD
$7.24M+33.2%

Other financials

Income statement

See full
Revenue$94.5M+19.3%
Gross profit$62.4M+20.5%
Net income-$26.9M-37.2%
EPS (diluted)-$0.47-34.3%

Balance sheet

See full
Cash & equivalents$11.4M-96.3%
Total debt$77.5M-2.4%
Total equity$340.1M-11.9%
Total assets$479.4M-6.6%

Cash flow

See full
Operating cash flow-$19.3M-28.0%
CapEx$3.0M+5.4%
Free cash flow-$22.2M-24.4%

Valuation

See full
Market cap$1.15B-25.9%
Enterprise value$1.21B—
P/S3.4×—

Profitability

See full
Gross margin64.2%0.0pp
Operating margin-33.9%+0.5pp
Net margin-32.5%+2.2pp
FCF margin-25.2%-4.6pp

Returns & leverage

See full
Return on equity-30.2%+5.2pp
Debt / equity0.2×0.0×
Current ratio6.5×-2.7×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: PROCEPT BioRobotics Corporation’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001588978-26-000030
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Research and development20,10117,63241,56734,034
Selling, general and administrative69,66856,303134,756111,499
Total operating expenses89,76973,935176,323145,533
Loss from operations(27,390)(22,189)(59,996)(49,626)
Interest expense(842)(895)(1,660)(1,773)
Interest and other income, net1,4653,6423,2087,172
Loss before provision for income taxes(26,767)(19,442)(58,448)(44,227)
Provision for income taxes941365189

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is PROCEPT BioRobotics Corporation's operating income?
PROCEPT BioRobotics Corporation (PRCT) reported operating income of -$27.39M in Q2 2026.
How has PROCEPT BioRobotics Corporation's operating income changed year-over-year?
PROCEPT BioRobotics Corporation's operating income decreased by 23.4% year-over-year, from -$22.19M to -$27.39M.
What is the long-term trend for PROCEPT BioRobotics Corporation's operating income?
Over 4 years (2021 to 2025), PROCEPT BioRobotics Corporation's operating income has grown at a 17.7% compound annual growth rate (CAGR), from -$54.16M to -$103.86M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about PROCEPT BioRobotics Corporation's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude